This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Noratech Pharmaceuticals, Inc., Nanjing Noratech Pharmaceuticals Co., Ltd. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Pan Chen: Innovator in Pharmaceutical Chemistry
Introduction
Pan Chen is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. With a total of 3 patents, his work focuses on innovative solutions for treating diseases related to acetylcholinesterase activity.
Latest Patents
Among his latest patents, one includes a donepezil derivative and its use. This invention relates to a donepezil derivative of general formula (I) or a pharmaceutically acceptable salt thereof. The compound is designed to be effective in preparing a medicament for treating diseases caused by abnormalities in acetylcholinesterase activity. Another significant patent involves methods for preparing deoxycholic acid (DCA) or its esters. These compounds are particularly useful for removing fat deposition, showcasing his commitment to addressing health-related issues.
Career Highlights
Pan Chen has worked with reputable companies in the pharmaceutical industry, including Noratech Pharmaceuticals, Inc. and Nanjing Noratech Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to important advancements in drug development.
Collaborations
Throughout his career, Pan Chen has collaborated with talented individuals such as Lulu Wang and Cuixia Zhang. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Pan Chen's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, making a significant impact in the field.